retatrutide telehealth Severe Obesity Trial Shows 30% Weight Loss New Weight Loss Drugs: Beyond
Description
Cons: Dishes - oh so many dishes
15,16 Jennings et al 15 demonstrated a significant decrease in weight (6.5 kg), HS Physicians Global Assessment (HS-PGA) (from 4 to 1), DLQI (from 24 to 14), and analgesic use (from daily to not daily) but no decrease in CRP (from 3 mg/dL) after eight weeks of treatment
Applied Mixed Models in Medicine (Wiley, 2014)
33 WattsNBBilezikianJPUsiskinKEdwardsRDesaiMLawGet al
Mid-dose tirzepatide users (7.5 to 10mg) should plan for 25 to 30 days
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: A randomised trial
